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β-Lactoglobulin (BLG) is a member of the lipocalin protein family and a major food-borne allergen in humans. Numerous in vitro studies have
suggested a role for BLG in molecular transport processes; however, its physiological role remains enigmatic. A cellular receptor for BLG has
been proposed, but has not yet been identified. Here we show that human LIMR, known to act as an endocytic receptor for lipocalin-1, also binds
bovine BLG and mediates its cellular uptake. The specificity of this interaction is corroborated by a complete block of cellular uptake of BLG in
the presence of LIMR antibodies or LIMR downregulation by antisense RNA. Furthermore, heterologous expression of human LIMR in insect
cells mediates cellular internalization of FITC-BLG. Since LIMR is highly expressed in the human intestine, it might also function in the uptake of
food-borne BLG.
© 2007 Elsevier B.V. All rights reserved.Keywords: β-Lactoglobulin; Endocytosis; Receptor; Lipocalin; LIMR1. Introduction
β-Lactoglobulin is a core member of the lipocalin family. It
is abundant in the milk of ruminants, and is present in many
other mammals, except primates [1–3]. BLG binds a variety of
hydrophobic molecules in vitro, such as fatty acids [4–8],
retinol and retinol derivatives [6,9], cholesterol [10], porphyrin
[9], bilirubin [11], alkaloids like piperine and aromatic
compounds like benzo(α)pyrene [12,13]. Furthermore, bovine
BLG is one of the three most common allergens in cow's milk
[14]. However, no definite physiological function could be
assigned to BLG so far. The currently most favoured hypothesis
attributes to it a role in molecular transport [1,3]. Several
attempts have been made to identify cellular receptors of BLG.Abbreviations: BLG, β-lactoglobulin; b, bovine; Lcn-1, lipocalin-1 (also
called tear lipocalin, or von Ebner's gland protein); Lcn-2, lipocalin-2 (also
called Ngal); LIMR, lipocalin-interacting-membrane-receptor; FITC, fluoresce-
in-isothiocyanate
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doi:10.1016/j.bbamem.2007.10.010Binding of BLG to specific cell surface receptors in the intestine
of neonate calves has been described [15], and also to bovine
germ cell plasma membrane fractions [16]. Transcytosis of
intact BLG across rabbit ileum in tissue chambers and across
CaCo-2 cells has been reported [17,18]. However, the identity
of the receptor(s) has remained unclear.
To date, four receptors for lipocalins have been identified.
Megalin, a member of the low-density lipoprotein receptor
family, is known to bind a large variety of mostly hydrophobic
ligands [19]. Among them there are several lipocalins, including
mouse retinol-binding protein, mouse urinary protein (MUP),
mouse odorant-binding protein, apolipoprotein M and human
Lcn-2 [20–23]. Novel cell surface receptors for mouse Lcn-2
(24p3R) and retinol-binding protein have been reported recently
[24,25]. In a previous study, we described a novel receptor for
Lcn-1, the lipocalin-interacting-membrane-receptor (LIMR),
which is present in a wide variety of organisms and is highly
conserved in mammals [26,27].
BLG has significant amino acid sequence homology and
structural similarity to Lcn-1 and binds some ligands, which are
known to be in vivo ligands of Lcn-1 [28,29]. Therefore, in the
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interact with BLG and to function as an endocytic receptor for
BLG.
2. Materials and methods
2.1. Purification of bBLG and FITC labeling of bBLG
bBLG was purified from milk of cows, homo-allelic for BLG, by a
procedure described previously [30]. FITC labeling of bBLG was done by
incubating purified bBLG with a 20-fold molar excess of FITC in 200 mM
sodium bicarbonate buffer, pH 9.0 for 2 h at room temperature. The reaction was
stopped by addition of NH4Cl to 50 mM and incubation for 1 h. Unconjugated
FITC was removed by gel-filtration on PD-10 columns (Amersham
Biosciences).
2.2. In vitro binding assays
For a binding assay in solution, a 6x His-tagged N-terminal fragment (aa 1-
59) of LIMR (10–20 μg) bound to Ni-NTA beads (50–100 μl) was incubated
with 2 μg of purified bBLG in 1 ml of 50 mMNaH2PO4/300 mMNaCl (pH 8.0)
at 4 °C for 2 h. The beads were then washed twice with 50 mM NaH2PO4/
300 mM NaCl (pH 8.0) buffer containing 1% Triton X-100. The His-tagged
LIMR fragment and any associated proteins were eluted with 250 mM
imidazole; 20 μl of each eluate was subjected to SDS-PAGE with subsequent
Coomassie blue staining or immunoblotting using a bBLG-specific antiserum
(ICL, Inc).
2.3. Cellular uptake studies
NT2 cells were grown on coverslips for 18 h at 37 °C in complete medium
(Minimal Essential Medium) containing 10% fetal bovine serum, 2 mM L-
glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin). SF9 cells were grown
on coverslips for 18 h at 27 °C in Grace's medium (Invitrogen). Cells were
washed once with serum-free medium and incubated for 3 h in serum-free
medium at 37 °C (NT2 cells) or 27 °C (SF9 cells). FITC-bBLG was added (final
concentration, 50 μg/ml each) followed by incubation for 1 h at 37 °C or 27 °C,
respectively. To remove cell surface-bound ligands that had not been
internalized, cells were washed twice with phosphate buffered saline (PBS)
and treated with 50 mM glycine, 150 mM NaCl, pH 3.0, for 2 min. Cells were
washed again with PBS and fixed in 100% ice-cold acetone for 5 min.Fig. 1. Interaction of LIMR with bBLG in vitro. (a) A 6x His tagged N-terminal LI
solution. Proteins were analyzed by 18% SDS-PAGE and Coomassie blue staining,
through of the Ni-NTA column; lanes W1, W3 andW5, first, third and fifth wash with
250 mM imidazole; lane InB, input of purified bBLG; lane InL, input of recombinant
LIMR were treated as above and analyzed by 18% SDS-PAGE and Coomassie blue s
Ni-NTA column; lanes W1, W3 and W5, first, third and fifth wash with 1% Triton X-2.4. Fluorescence microscopy and image analysis
Analysis of FITC-bBLG uptake was performed using a Carl Zeiss Axioplan
fluorescence microscope or by laser scanning confocal microscope. When
employing the latter, cells were imaged with an inverse IX70 Olympus
microscope mounted to the UltraVIEW RS 3-line confocal System (Perkin
Elmer) equipped with a three-line Argon-Krypton laser (488/568/647 nm) and a
×100/×40 PlanApo (numerical aperture 1.4 oil) objective (Olympus). Image
acquisition and processing was carried out with UltraVIEW™software (Perkin
Elmer). Confocal images captured as a stack of images at different focal points
(at 0.2 μm steps) were processed with Volocity™ 3D/4D visualisation software
(Improvision Inc.).
2.5. Antisense down regulation of LIMR expression in NT2 cells
Vector construction of a LIMR antisense plasmid and transfection of NT2
cells was done essentially as described previously [27].
2.6. Construction of a LIMR expression vector and transfection of SF9
cells
To construct a vector for expression of LIMR in SF9 cells, a PCR fragment
was amplified from a plasmid [26] using upstream primer: 5′-TCC CCC GGG
ATGGAAGCACCTGAC TAC-3′ and downstream primer: 5′-GCTCTAGAT
CAC TGG TGC TGG GTC TT-3′. The PCR product was gel-purified, digested
with SmaI and XbaI and ligated with the SmaI/XbaI digested vector pOPRSVI/
MCS (Stratagene). Transfection of SF9 cells was done using Cellfectin Reagent
(Invitrogen) according to the manufacturer's recommendations.
3. Results
3.1. bBLG binds to the N-terminal domain of LIMR
In a previous study we showed that the N-terminal
extracellular domain of LIMR is essential for its interaction
with Lcn-1 [26]. To examine if this domain of LIMR is able to
interact with BLG, we have incubated purified bBLG with a
His-tagged recombinant N-terminal fragment (aa 1–59) of
LIMR immobilized to Ni-NTA beads. Potential complexes
bound to Ni-NTA-agarose beads were eluted and analyzed byMR fragment (aa 1–59) bound to Ni-NTA beads was incubated with bBLG in
and Western blotting using bBLG antibodies. Lane M, marker; lane FT, flow-
1% Triton X-100/phospate buffer (pH 8.0); lane E, elution of bound proteins by
His-tagged N-terminal LIMR fragment. (b) For a control Ni-NTA beads without
taining, and Western blotting (b). Lane M, marker; lane FT, flow-through of the
100/phosphate buffer (pH 8.0); lane E, eluate; lane InB, input of purified bBLG.
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antiserum (Fig. 1a). When bBLG was incubated with LIMR-
coated beads, it was retained on the beads even after several
washings and was eluted by 250 mM imidazole (Fig. 1a, lane
E). In contrast, no binding of bBLG was observed with Ni-NTA
beads lacking LIMR (Fig. 1b, lane e), indicating that bBLG
physically interacts with the N-terminal fragment of LIMR.Fig. 2. Analysis of LIMR-mediated cellular internalization of FITC-bBLG inNT2 cells
Uptake studies in the presence of anti-LIMR antibodies: fluorescence microscopy (
expressing LIMR-antisense RNA (d), and mock-transfected cells (e).3.2. Cellular internalization of BLG by LIMR in human NT2
cells
In a previous study, we found that human NT2 cells express
LIMR [26]. Therefore, NT2 cells were incubated with FITC-
labeled bBLG and examined by fluorescence microscopy to
study the cellular uptake of BLG. Endocytic uptake of FITC-. Confocal fluorescencemicroscopy of NT2 cells incubatedwith FITC-bBLG (a).
b), and corresponding phase contrast image (c). Uptake studies with NT2 cells
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intracellular staining detected by confocal fluorescent micros-
copy (Fig. 2a).
Blocking experiments, using polyclonal antibodies against
the N-terminal fragment of LIMR as well as knock-down ofFig. 3. Expression of LIMR in insect SF9 cells. Fluorescence microscopy of SF9
cells transfected with a LIMR cDNA expressing vector stained with anti-LIMR
antibodies (a). No LIMR specific staining was obtained with mock-transfected
SF9 cells (b). Phase contrast image of mock-transfected cells (c).LIMR by the expression of antisense RNA clearly demonstrated
that LIMR is responsible for the observed internalization of
bBLG. Pretreatment of the NT2 cells with anti-LIMR antibodies
completely blocked cellular uptake of bBLG (Fig. 2b). Also, a
drastic decrease in intracellular fluorescence intensity was ob-
served in the NT2 cells expressing antisense LIMR RNA
(Fig 2d). In contrast, the mock-transfected cells showed a
similar cytoplasmatic fluorescence staining as the wild type
NT2 cells (Fig. 2e).
3.3. Cellular internalization of BLG by heterologous
expression of LIMR in insect SF9 cells
In order to confirm the results obtained with human NT2
cells, we expressed human LIMR in a heterologous insect cell
system (SF9 cells from Spodoptera frugiperda). Immunofluo-
rescence analysis of the transfected cells using LIMR-specific
antibodies revealed high levels of LIMR expression (Fig. 3),
with the more intense staining of the cell membrane indicating
correct cellular targeting of the recombinant receptor (Fig. 3a).
No significant staining was obtained with mock-transfected SF9
cells (Fig. 3b). Next, we incubated the LIMR-transfected SF9
cells and control cells with FITC-bBLG. The LIMR-expressing
SF9 cells produced a bright intracellular fluorescence (Fig. 4a),
and confocal fluorescence microscopy revealed in LIMR-
expressing SF9 cells a granular cytoplasmic staining very sim-
ilar to that obtained with the NT2 cells (Fig. 4b). In contrast, no
accumulation of fluorescence was detected in the mock-
transfected cells (Fig. 4c).
4. Discussion
Delivery of their hydrophobic ligands through binding to
specific cell surface receptors seems to be a general feature of
most lipocalins [31–33]. Several types of receptors have been
suggested to mediate ligand transfer through the cell membrane
[32]. These include pore-like receptors, internalization of the
entire ligand–lipocalin complex by endocytic receptors, or a
mechanism where the ligand is released from the lipocalin
outside the cell and is actively transported by the receptor to a
cytosolic binding protein. However, with the exception of the
transport of retinol by retinol-binding protein, which was shown
to be delivered by this latter type of receptor [25,34,35], all
lipocalin receptors identified so far act as endocytic receptors
[23,24,27]. Our experiments provide clear evidence in support
of the concept that BLG also is internalized by an endocytic
mechanism mediated by the Lcn-1 receptor LIMR. This result is
not entirely unexpected, since Lcn-1 and BLG share high
structural similarity and very similar ligand binding activities
[36,37]. In addition, LIMR has been found to mediate cellular
uptake of uteroglobin [38], which shares several features with
lipocalins. Our findings are in agreement with earlier observa-
tions on the transport of BLG across the rabbit ileum, indicating
that BLG is efficiently absorbed by the intestinal mucosa in its
intact antigenic form and demonstrating that this transport is
significantly reduced by the microtubule assembly inhibitor
colchicine [17].
Fig. 4. Uptake of FITC-bBLG in LIMR expressing SF9 cells. Fluorescence microscopy (a) and confocal laser microscopy (b) of LIMR expressing SF9 cells incubated
with FITC-bBLG; n, nucleus. Mock-transfected cells incubated with FITC-bBLG (c). Phase-contrast image of mock-transfected cells (d).
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has not yet been isolated. Nevertheless, a partial cDNA clone
(BC111204.1) was isolated from Bos taurus, which contains an
open reading frame showing 90% sequence identity with the
sequence of human LIMR suggesting that a LIMR-like protein is
expressed in the cow.
Since the physiological ligand of BLG is still not known, we
cannot draw any conclusion on the biological function of the
LIMR mediated BLG uptake in BLG producing animals.
Cellular internalization of BLG by LIMR might be a
mechanism for scavenging of potentially harmful ligands,
leading to their detoxification and degradation, as supposed for
Lcn-1 [39]. On the other hand, LIMR-mediated internalization
of BLG might lead to more complex reactions, as described
with uteroglobin. LIMR dependent cellular uptake of uteroglo-
bin has been found to trigger anti-inflammatory and anti-
chemotactic properties [38,40].
Humans do not possess a BLG gene. Nevertheless, we
suggest that LIMR might play an important role in the uptake of
BLG from food sources, because it is highly expressed in tissues
of the human gastrointestinal tract [26]. In this process, LIMR
might act in two opposing ways. It might trigger immunoreac-
tions associated with BLG as a food-borne allergen that isresponsible for milk protein immunoreactivity and intolerance
[41]. Alternatively, it might help to internalize BLG for degra-
dation, thus preventing allergic response.
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